Literature DB >> 32627170

Heterologous expression of concatenated nicotinic ACh receptors: Pros and cons of subunit concatenation and recommendations for construct designs.

Vivian Wan Yu Liao1,2, Ali Saad Kusay1,2, Thomas Balle1,2, Philip Kiaer Ahring1,2.   

Abstract

BACKGROUND AND
PURPOSE: Concatenation of Cys-loop receptor subunits is a commonly used technique to ensure experimental control of receptor assembly. However, we recently demonstrated that widely used constructs did not lead to the expression of uniform pools of ternary and more complex receptors. The aim was therefore to identify viable strategies for designing concatenated constructs that would allow strict control of resultant receptor pools. EXPERIMENTAL APPROACH: Concatenated dimeric, tetrameric, and pentameric α4β2-containing nicotinic ACh (nACh) receptor constructs were designed with successively shorter linker lengths and expressed in Xenopus laevis oocytes. Resulting receptor stoichiometries were investigated by functional analysis in two-electrode voltage-clamp experiments. Molecular dynamics simulations were performed to investigate potential effects of linkers on the 3D structure of concatemers. KEY
RESULTS: Dimeric constructs were found to be unreliable and should be avoided for expression of ternary receptors. By introducing two short linkers, we obtained efficient expression of uniform receptor pools with tetrameric and pentameric constructs. However, linkers should not be excessively short as that introduces strain on the 3D structure of concatemers. CONCLUSION AND IMPLICATIONS: The data demonstrate that design of concatenated Cys-loop receptors requires a compromise between the desire for control of assembly and avoiding introduction of strain on the resulting protein. The overall best strategy was found to be pentameric constructs with carefully optimised linker lengths. Our findings will advance studies of ternary or more complex Cys-loop receptors as well as enabling detailed analysis of how pharmacological agents interact with stoichiometry-specific binding sites.
© 2020 The British Pharmacological Society.

Entities:  

Keywords:  Cys-loop; NS9283; acetylcholine; concatenated; expression; nicotine; receptor

Mesh:

Substances:

Year:  2020        PMID: 32627170      PMCID: PMC7443467          DOI: 10.1111/bph.15188

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Analysis of forces that determine helix formation in alpha-proteins.

Authors:  Gelena T Kilosanidze; Alexey S Kutsenko; Natalia G Esipova; Vladimir G Tumanyan
Journal:  Protein Sci       Date:  2004-02       Impact factor: 6.725

2.  Expression of functional human α6β2β3* acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers.

Authors:  Alexandre Kuryatov; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2010-10-05       Impact factor: 4.436

Review 3.  Tandem couture: Cys-loop receptor concatamer insights and caveats.

Authors:  Spencer S Ericksen; Andrew J Boileau
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

4.  A GABA(A) receptor of defined subunit composition and positioning: concatenation of five subunits.

Authors:  Roland Baur; Frédéric Minier; Erwin Sigel
Journal:  FEBS Lett       Date:  2006-02-17       Impact factor: 4.124

5.  Unanticipated structural and functional properties of delta-subunit-containing GABAA receptors.

Authors:  Kuldeep H Kaur; Roland Baur; Erwin Sigel
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

6.  Diversity of structure and function of alpha1alpha6beta3delta GABAA receptors: comparison with alpha1beta3delta and alpha6beta3delta receptors.

Authors:  Roland Baur; Kuldeep H Kaur; Erwin Sigel
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

7.  Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers.

Authors:  Michael J Curtis; Steve Alexander; Giuseppe Cirino; James R Docherty; Christopher H George; Mark A Giembycz; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Yong Ji; David J MacEwan; Christopher G Sobey; S Clare Stanford; Mauro M Teixeira; Sue Wonnacott; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2018-04       Impact factor: 8.739

8.  Ligand Binding at the 4-4 Agonist-Binding Site of the 42 nAChR Triggers Receptor Activation through a Pre-Activated Conformational State.

Authors:  Dinesh C Indurthi; Trevor M Lewis; Philip K Ahring; Thomas Balle; Mary Chebib; Nathan L Absalom
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

9.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  OpenMM 7: Rapid development of high performance algorithms for molecular dynamics.

Authors:  Peter Eastman; Jason Swails; John D Chodera; Robert T McGibbon; Yutong Zhao; Kyle A Beauchamp; Lee-Ping Wang; Andrew C Simmonett; Matthew P Harrigan; Chaya D Stern; Rafal P Wiewiora; Bernard R Brooks; Vijay S Pande
Journal:  PLoS Comput Biol       Date:  2017-07-26       Impact factor: 4.475

View more
  2 in total

1.  Heterologous expression of concatenated nicotinic ACh receptors: Pros and cons of subunit concatenation and recommendations for construct designs.

Authors:  Vivian Wan Yu Liao; Ali Saad Kusay; Thomas Balle; Philip Kiaer Ahring
Journal:  Br J Pharmacol       Date:  2020-08-05       Impact factor: 8.739

2.  Targeting the cell's gatekeepers for novel drug discovery.

Authors:  Gary J Stephens; Arun K Shukla
Journal:  Br J Pharmacol       Date:  2022-04-07       Impact factor: 9.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.